An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
about
Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells.MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.Hypoxia, Metabolism and Immune Cell Function.Vitamin C and immune cell function in inflammation and cancer
P2860
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
@en
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
@nl
type
label
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
@en
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
@nl
prefLabel
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
@en
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
@nl
P2093
P2860
P50
P1433
P1476
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
@en
P2093
Ananda W Goldrath
Anthony T Phan
Jonas Bergh
Niklas Loman
Nikola Vojnovic
Petros A Tyrakis
Susan Fitzpatrick
Thomas Hatschek
P2860
P304
669-683.e5
P356
10.1016/J.CCELL.2017.10.003
P50
P577
2017-11-01T00:00:00Z